DISTRIBUTION AND URINARY-EXCRETION OF ALUMINUM INJECTED WITH SEVERAL ORGANIC-ACIDS INTO MICE - RELATIONSHIP WITH CHEMICAL-STATE IN SERUM STUDIED BY THE HPLC-ICP METHOD

被引:22
作者
MAITANI, T
KUBOTA, H
HORI, N
YOSHIHIRA, K
TAKEDA, M
机构
[1] National Institute of Hygienic Sciences, Tokyo, 158, Kamiyoga 1–18–1, Setagaya
关键词
ALUMINUM; ORGANIC ACID; ICP; HPLC-ICP; MOUSE; CITRATE; MALATE; TARTRATE; ISOCITRATE; DEFEROXAMINE;
D O I
10.1002/jat.2550140403
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The correlation between the in vivo tissue distribution or the urinary excretion of aluminium (Al) administered with four organic acids and the in vitro binding of Al to serum protein in the presence of the organic acids was studied. Aluminium was injected intraperitoneally into mice with an organic acid at a dose of 20 mg Al kg(-1) (Al:ligand= 1:1 or 1:3). When the Al-citrate mixture was administered, hepatic and renal concentrations of Al at 3 h were low, while hepatic Al concentrations for the other three organic acids (malate, tartrate and isocitrate) were considerably higher. Compared to the sole administration of Al, urinary excretion of Al was at a high level in all organic acids. Aluminium added in vitro to control serum as an Al-citrate mixture was present only in a low-molecular-weight (LMW) fraction, while Al added with other organic acids was present in both the high-molecular-weight (HMW) and LMW fractions. Consequently, it was interpreted that Al in the LMW fractions was excreted into the urine and that a significant part of Al in the HMW fractions was transferred to the liver. The binding status of Al in serum observed in the in vitro study was also manifested in the in vivo samples obtained after the intravenous injection.
引用
收藏
页码:257 / 261
页数:5
相关论文
共 20 条
[1]   DIALYSIS ENCEPHALOPATHY SYNDROME - POSSIBLE ALUMINUM INTOXICATION [J].
ALFREY, AC ;
LEGENDRE, GR ;
KAEHNY, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (04) :184-188
[2]  
ALFREY AC, 1980, NEUROTOXICOLOGY, V1, P43
[3]  
BERTHOLF RL, 1984, BIOCHEM BIOPH RES CO, V125, P1020, DOI 10.1016/0006-291X(84)91385-8
[4]  
CHANG TMS, 1983, LANCET, V2, P1051
[5]  
CHERIAN MG, 1983, TOXICOLOGY, V26, P161
[6]   COMPARATIVE EFFECTS OF SEVERAL CHELATING-AGENTS ON THE TOXICITY, DISTRIBUTION AND EXCRETION OF ALUMINUM [J].
DOMINGO, JL ;
GOMEZ, M ;
LLOBET, JM ;
CORBELLA, J .
HUMAN TOXICOLOGY, 1988, 7 (03) :259-262
[7]   ALUMINUM TRANSPORT IN BLOOD-SERUM - BINDING OF ALUMINUM BY HUMAN TRANSFERRIN IN THE PRESENCE OF HUMAN ALBUMIN AND CITRATE [J].
FATEMI, SJA ;
KADIR, FHA ;
MOORE, GR .
BIOCHEMICAL JOURNAL, 1991, 280 :527-532
[8]   GASTROINTESTINAL ABSORPTION OF ALUMINUM FROM ALUMINUM-CONTAINING ANTACIDS [J].
KAEHNY, WD ;
HEGG, AP ;
ALFREY, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (24) :1389-1390
[9]  
KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758
[10]   NEPHROTOXICITY OF INTRAVENOUSLY INJECTED CADMIUM METALLOTHIONEIN - CRITICAL CONCENTRATION AND TOLERANCE [J].
MAITANI, T ;
CUPPAGE, FE ;
KLAASSEN, CD .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1988, 10 (01) :98-108